Source: Bioorganic & Medicinal Chemistry. Unidades: FFCLRP, FCFRP
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS, SÍNTESE QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Peterson de et al. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry, v. 27, n. 6, p. 931-943, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2018.12.030. Acesso em: 08 nov. 2024.APA
Andrade, P. de, Mantoani, S. P., Nunes, P. S. G., Magadán, C. R., Perez, C., Xavier, D. J., et al. (2019). Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry, 27( 6), 931-943. doi:10.1016/j.bmc.2018.12.030NLM
Andrade P de, Mantoani SP, Nunes PSG, Magadán CR, Perez C, Xavier DJ, Sakamoto-Hojo ET, Campillo NE, Martínez A, Carvalho I. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease [Internet]. Bioorganic & Medicinal Chemistry. 2019 ; 27( 6): 931-943.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.bmc.2018.12.030Vancouver
Andrade P de, Mantoani SP, Nunes PSG, Magadán CR, Perez C, Xavier DJ, Sakamoto-Hojo ET, Campillo NE, Martínez A, Carvalho I. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease [Internet]. Bioorganic & Medicinal Chemistry. 2019 ; 27( 6): 931-943.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.bmc.2018.12.030